Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2010
12/16/2010CA2761607A1 Melanocortin receptor-specific peptides
12/16/2010CA2761121A1 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
12/15/2010EP2261380A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261378A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261377A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261376A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261375A2 Method of Preventing Virus:Cell Fusion By Inhibiting the Function of the Fusion Initiation Region in RNA Viruses Having Class I Membrane Fusogenic Envelope Proteins
12/15/2010EP2261374A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins
12/15/2010EP2261364A2 Chloroplasts engineered to express pharmaceutical proteins
12/15/2010EP2261358A2 Novel streptococcus antigen
12/15/2010EP2261357A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261356A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261355A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261354A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261353A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261352A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261351A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261350A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261349A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261348A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261347A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261346A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261345A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261344A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261343A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261342A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261341A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261340A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261339A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261338A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261337A1 DNA sequence and recombinant production of group 4 major allergens from cereals
12/15/2010EP2261336A1 DNA sequence and recombinant production of group 4 major allergens from cereals
12/15/2010EP2261335A1 Compositions and methods for increasing bone mineralisation
12/15/2010EP2261330A1 Factor VII Glycoforms
12/15/2010EP2261328A1 Lipase variants for pharmaceutical use
12/15/2010EP2261317A1 Microorganism producing cyclic compound
12/15/2010EP2261256A2 Methods of inhibiting metastasis
12/15/2010EP2261251A2 Methods for the synthesis of a modified hemoglobin solution
12/15/2010EP2261250A1 Albumin fusion proteins
12/15/2010EP2261249A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261248A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261247A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261246A2 Binding polypeptides for B-lymphocyte stimulator protein (BLyS)
12/15/2010EP2261244A2 Human il-18 substitution mutants and their conjugates
12/15/2010EP2261241A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2010EP2261238A1 Cyclic compound and salt thereof
12/15/2010EP2261237A2 Daptomycin and related analogs in crystalline form, their preparation and use
12/15/2010EP2261236A2 Composition for proteasome inhibition
12/15/2010EP2261235A2 Inhibitors of caspases
12/15/2010EP2261234A2 Inhibitors of caspases
12/15/2010EP2261233A2 Inhibitors of caspases
12/15/2010EP2261232A2 Inhibitors of caspases
12/15/2010EP2261229A2 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
12/15/2010EP2260872A2 Polymer conjugates of interferon beta-1A and uses thereof
12/15/2010EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents
12/15/2010EP2260866A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
12/15/2010EP2260864A1 Therapeutic applications
12/15/2010EP2260860A1 Calcium phosphate delivery vehicles for osteoinduktive proteins
12/15/2010EP2260859A1 Compounds acting as peptide gap junction modulators and their uses
12/15/2010EP2260858A2 Monomethylvaline compounds capable of conjugation to ligands
12/15/2010EP2260857A1 Novel applications of HIP/PAP or derivatives thereof
12/15/2010EP2260843A2 Alpha-MSH and derivatives for the induction of tolerance against antigens
12/15/2010EP2260838A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
12/15/2010EP2260100A1 tPA MUTANT IN THE TREATMENT OF ACUTE BRAIN INJURY AND NEURODEGENERATIVE DISORDERS
12/15/2010EP2260098A1 Treating cancer
12/15/2010EP2259807A1 Compositions and methods for distraction osteogenesis
12/15/2010EP2259799A1 Combination of immunomodulator and anti-pathogenic agent
12/15/2010EP2259794A1 Method for treatment of photosensitivity and phototoxicity
12/15/2010EP2259793A2 Use of corticotropin-releasing factor for the treatment of cancer
12/15/2010EP2259792A1 Methods for treating and preventing brain tumors based on bone morphogenetic proteins
12/15/2010EP2259791A2 Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
12/15/2010EP2259775A2 System for delivery of protein in insoluble fibrillar or aggregate form
12/15/2010EP2259768A1 Compositions containing cyclic peptides and methods of use
12/15/2010EP1855716B1 Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
12/15/2010EP1838172B1 Novel nutraceutical compositions
12/15/2010EP1778724B1 Antiangiogenic peptides
12/15/2010EP1761253B1 Hyaluronic acid in the enhancement of lens regeneration
12/15/2010EP1694709B1 Recombinant anti-cd64-eta' immunotoxins
12/15/2010EP1678297B1 Method for producing gamma-carboxylated proteins
12/15/2010EP1677808B1 Combined preparation for treating sepsis
12/15/2010EP1635855B1 Selective r-cadherin antagonists and methods
12/15/2010EP1610803B1 LH for use in maintaining one or more pregnancies by inducing accesory copus luteum formation.
12/15/2010EP1601756B1 Methods for the preparation of alpha (2) macroglobulin-antigenic molecule complexes
12/15/2010EP1525313B1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase
12/15/2010EP1353942B1 Peptide inhibitors of hiv entry
12/15/2010EP1112077B1 Method for detection of biological factors in epidermis
12/15/2010EP1076703B2 Therapeutic uses of il-17 homologous polypeptides
12/15/2010EP1053001B1 Novel mixed amylin activity compounds
12/15/2010CN1993138B Method of stabilizing proteins
12/15/2010CN1968678B External preparation for the skin
12/15/2010CN1852920B Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
12/15/2010CN1824292B Medicine for improving brain function its preparation method and use
12/15/2010CN1802386B GLP-1 analog fusion proteins
12/15/2010CN1665932B Vectors with modified protease-dependent tropism
12/15/2010CN101918556A Cell permeable NM23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same
12/15/2010CN101918547A Recombinant elastase proteins and methods of manufacturing and use thereof
12/15/2010CN101918546A Use of a chromatography substrate for reducing the amount of ADAMTS13 in a solution derived from plasma
12/15/2010CN101918440A Novel avian cytokines and genetic sequences encoding same
12/15/2010CN101918034A TAZ/WWTR1 for diagnosis and treatment of cancer
12/15/2010CN101918032A Cross-linked hydrogel containing an active substance
1 ... 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 ... 3163